Stock listing

Briacell Therapeutics Corp

Selected listing: BCT · TSX · CAD · CA

Briacell Therapeutics Corp (TSX:BCT), Health Technology. Latest release Oct 6, 2026: BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting.

BCT:TSXCADCAUpdated October 2, 2026

Ticker: TSX:BCT
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: TSX
Currency: CAD

About Briacell Therapeutics Corp

Briacell Therapeutics Corp (BCT) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Briacell Therapeutics Corp

BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting

October 6, 2026

Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study

September 14, 2026

BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center

September 8, 2026

BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+(TM)

August 24, 2026

BriaCell Receives FDA Clearance to Initiate Bria-PROS+(TM) Clinical Study in Prostate Cancer

August 5, 2026

All Briacell Therapeutics Corp news →

Research Briacell Therapeutics Corp

Briacell Therapeutics Corp company profile

View the public company page for Briacell Therapeutics Corp on 6ix.

Briacell Therapeutics Corp news

Read company news and market updates connected to Briacell Therapeutics Corp.

Briacell Therapeutics Corp investor events

Find investor webinars, events, and replay context for Briacell Therapeutics Corp.